Research – The Triad Program
Related Articles
- Dec 18, 2011 -
HNF to fund promising research on Charcot-Marie-Tooth: Planning, shopping, wrapping, baking--December can be so exhausting. In the middle of all the holiday activity, HNF would like to stop and shout a huge “thank you” to our supporters! Please read the l Read More... - Dec 6, 2011 - CMT Research Update: HNF-Funded Projects: HNF puts your dollars to work! We are currently funding two very important research projects, one for CMT type 1 and the other for CMT type 2A.
Charcot-Marie-Tooth, Type 1
CMT type 1 is caused b Read More...
People-Centered. Cure-Driven. The Hereditary Neuropathy Foundation.
HNF has developed an innovative research program called the Therapeutic Research in Accelerated Discovery (TRIAD) program. The TRIAD program is designed to encourage cutting-edge research at a progressive pace while addressing the specific needs of people with CMT.
We have identified our research priorities as follows:
Clinical Therapeutics: Research that will lead to improved therapies for people living with CMT,
Basic Science: Research that will lead to a greater understanding of CMT, and
Drug Discovery: Drug Discovery: Research that has considerable potential for a cure for CMT.
The TRIAD program promotes accelerated discovery by establishing a collaborative research process that has defined goals for each funded lab and requires the sharing of discovery at each stage of research. We believe that this multi-tiered approach will help people with CMT live a better life while we develop effective therapies, treatments, and a cure for CMT.
Recent Comments